ABSTRACT Introduction: Primary Sjögren's syndrome (pSS) is an autoimmune systemic
disease characterized by a complex and not yet completely elucidated etiopathogenesis …

ABSTRACT Introduction: Primary Sjögren syndrome (pSS) is a systemic autoimmune
disease that may affect 3 in 1,000 people within the general population. The therapeutic …

For many years primary Sjögren's syndrome (pSS) has been considered an orphan disease,
since no specific therapies were recognized as being capable of contrasting the …

Primary Sjögren syndrome (pSS) is a progressive autoimmune disease characterized by
sicca and systemic manifestations. In this Review, we summarize the available data on …

Primary Sjögren's syndrome (pSS) is a complex and heterogeneous disease. Last year, a
great deal of basic and clinical research was carried out in pSS. Following the previous …

ABSTRACT Introduction: Primary Sjögren's (pSS) syndrome is a chronic, autoimmune, and
systemic disease characterized by xerostomia, xerophthalmia, muscle pain and fatigue. The …

Primary Sjögren syndrome (pSS) is a systemic autoimmune disease that is characterized by
a triad of symptoms that affect all patients (dryness, pain and fatigue). In addition, systemic …

To date, no immunomodulatory drug has proved efficacious in primary Sjögren's syndrome
(pSS). In pSS, difficulties in drug efficacy assessment is related to the large spectrum of …

Sjögren Syndrome (SS) is a systemic autoimmune disease with a wide clinical spectrum that
extends from sicca symptoms of the mucosal surfaces to extra-glandular systemic …

Primary Sjögren's syndrome (pSS) is an autoimmune exocrinopathy characterized by
dryness symptoms. This review briefly describes recent advances in the targeted therapies …